Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T9556 |
TNIK-IN-3
|
Wnt/beta-catenin | Cytoskeletal Signaling; Stem Cells |
TNIK-IN-3 is a highly potent and orally active inhibitor of Traf2- and Nck-interacting protein kinase (TNIK). It exhibits a strong selectivity for TNIK with an IC50 value of 0.026 μM. Additionally, TNIK-IN-3 demonstrates inhibitory activity against Flt4 (IC50 = 0.030 μM), Flt1 (IC50 = 0.191 μM), and DRAK1 (IC50 = 0.411 μM). This compound holds potential for carrying out research on colorectal cancer (CRC) [1]. | |||
T9810 |
TNIK-IN-5
|
Wnt/beta-catenin | Cytoskeletal Signaling; Stem Cells |
TNIK-IN-5 是高效的 TNIK 抑制剂 (IC50= 0.05 μM)。TNIK-IN-5 可以有效抑制细胞中的 Wnt 信号通路。TNIK-IN-5 在体外显示出良好的抗结直肠癌活性。 | |||
T9557 |
TNIK-IN-2
|
Wnt/beta-catenin | Cytoskeletal Signaling; Stem Cells |
TNIK-IN-2 是有效的TNIK 抑制剂,IC50为 1.3337 μM。 | |||
T26282 |
TNIK-IN-1
TNIK-inhibitor-1,TNIK inhibitor 1 |
||
TNIK-IN-1 is an inhibitor of Traf2- and Nck-interacting kinase (TNIK). | |||
T77719 |
TNIK-IN-7
|
Wnt/beta-catenin | Cytoskeletal Signaling; Stem Cells |
TNIK-IN-7 是一种具有高效性和选择性的 Traf2 和 Nck 相互作用激酶 (TNIK) 抑制剂(IC50:11 nM),具有抗肿瘤活性,可用于研究结直肠癌细胞中信号传导和增殖。 | |||
T80971 |
TNIK-IN-6
|
||
TNIK-IN-6 (Compound 9) 是一种Traf2和Nck相互作用激酶(TNIK)的抑制剂,具有0.93 nM的IC50,对神经与精神疾病具有重要影响。 | |||
T61396 |
TNIK-IN-4
|
||
TNIK-IN-4, a powerful TNIK inhibitor, exhibits an IC50 value of 0.61 μM. Furthermore, it demonstrates inhibitory effects on the HCT116 cell line, which is representative of colorectal cancer [1]. | |||
T79794 |
TNIK&MAP4K4-IN-1
|
||
TNIK&MAP4K4-IN-1(化合物A-39)作为TNIK和MAP4K4/HGK的双效抑制剂,在LX-2人肝星状细胞中,其IC50为1.29 nM和<10 nM。该化合物适用于癌症和纤维化治疗。 | |||
T11793 |
KY-05009
|
Wnt/beta-catenin | Cytoskeletal Signaling; Stem Cells |
KY-05009 是 ATP 竞争性的、有效的 TNIK 抑制剂,Ki 为 100 nM。KY-05009抑制人肺腺癌细胞中 TGF-β1 诱导的上皮-间质转化。KY-05009 还抑制TNIK 的蛋白表达和Wnt 靶基因的转录活性,并诱导癌细胞凋亡,显示抗癌活性。 | |||
T26110 |
Robotnikinin
|
||
Robotnikinin is an Shh signaling inhibitor in a concentration-dependent manner. It acts by exhibiting significant repression of Shh-induced Gli1/Gli2. | |||
T4011 |
NCB-0846
NCB 0846 |
MAPK; Wnt/beta-catenin | Cytoskeletal Signaling; MAPK; Stem Cells |
NCB-0846 是一种具有口服活性的TNIK 抑制剂(IC50:21 nM)。 | |||
T68051 |
Delequamine
RS 15385-197 |
Adrenergic Receptor | GPCR/G Protein; Neuroscience |
Delequamine (RS 15385-197) 是一种有效的选择性 α2-肾上腺素受体拮抗剂。 | |||
T77660 |
TINK-IN-1
|
Wnt/beta-catenin | Cytoskeletal Signaling; Stem Cells |
TINK-IN-1 是一种具有选择性和高效性的 TNIK 抑制剂(IC50:8 nM)。TINK-IN-1 抑制结直肠癌细胞活力,可用于研究智力发育障碍。 | |||
T5093 |
Pim1/AKK1-IN-1
LKB1/AAK1 dual inhibitor,MDK-2275 |
Pim; Hippo pathway | Chromatin/Epigenetic; JAK/STAT signaling; Stem Cells |
Pim1/AKK1-IN-1 (LKB1/AAK1 dual inhibitor) 是多种酶抑制剂,能够作用于Pim1、AKK1、MST2 和 LKB1,Kd 值分别为 35、53、75 和 380 nM,还抑制 MPSK1 和 TNIK。 | |||
T5483 |
DMX-5804
DMX-5084 |
MAPK | MAPK |
DMX-5804 是一种口服有活性的MAP4K4选择性抑制剂,其对人 MAP4K4 的IC50=3 nM,pIC50=8.55。对 MINK1/MAP4K6 (pIC50=8.18) 和 TNIK/MAP4K7 (pIC50=7.96) 的作用相对较弱。它可以提高心肌细胞存活率,降低小鼠的缺血再灌注损伤。 | |||
T28370 |
PF-06279794
PF 794,PF794,PF-794,PF 06279794 |
||
PF-06279794 is a potent, selective and ATP-competitive TNIK inhibitor. | |||
T79908 |
ON 108600
|
Casein Kinase | Metabolism; Stem Cells |
ON 108600 作为CK2(Casein Kinase2)/TNIK/DYRK1抑制剂,对DYRK1A/DYRKB、DYRK2、CK2α1/CK2α2及TNIK展示IC50值,分别为0.016 μM/0.007 μM、0.028 μM、0.05 μM/0.005 μM和0.005 μM。该化合物显示出抗肿瘤活性。 | |||
T33945 |
PF-06260933 HCl
PF06260933 dihydrochloride,PF-06260933 dihydrochloride,PF 06260933 dihydrochloride |
||
PF-06260933 Dihydrochloride is a MAP4K4 (HGK) inhibitor (IC50 = 140 nM). It can improve the fasting hyperglycemia in mice. In addition, it inhibited Mink and Tnik (IC50 values of 8 and 13 nM, respectively). | |||
T36016 | PF 06260933 dihydrochloride | ||
MAP4K4 (HGK) inhibitor (IC50 = 140 nM). Also inhibits MINK and TNIK (IC50 values are 8 and 13 nM, respectively). Improves fasting hyperglycemia in mice. Orally active. Ammirati et al (2015) Discovery of an in vivo tool to establish proof-of-concept for MAP4K4-based antidiabetic treatment. ACS Med.Chem.Lett. 6 1128 PMID:26617966 |